Lisa A. Lacasse: One of our key priorities at the ACS CAN is to advance the Prostate-Specific Antigen Screening for High-risk Insured Men
Lisa A. Lacasse, President at American Cancer Society Cancer Action Network, shared a post on LinkedIn:
“One of our key priorities at the American Cancer Society Cancer Action Network (ACS CAN) is to advance the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act to eliminate barriers to prostate cancer screening. We continue to urge Congress to pass the PSA Screening for HIM Act (H.R. 1826). All men at high-risk for prostate cancer who decide to move forward with screening after a discussion with their health care provider should have barrier-free access without cost sharing. We are partnering with lawmakers to secure more support for this legislation and will work hard to get this bill across the finish line. Read more in this Question and Answer with me.
Now is the time to focus on combating prostate cancer through legislative change to promote equitable access to care and improve cancer outcomes. The American Cancer Society as a whole is improving the lives of people with cancer and their families each day as the only organization combating cancer through advocacy, research, and patient support.
Be part of a meaningful collaboration that can help save lives. Together, we can end cancer as we know it, for everyone.
Learn more about how to become an ACS partner.”
Source: Lisa A. Lacasse/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023